Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer

TradingKey - In the early hours of April 19, AST SpaceMobile’s (ASTS.US) seventh broadband communication satellite, BlueBird 7, launched from Cape Canaveral aboard Blue Origin’s New Glenn rocket. While the rocket’s first stage was successfully recovered, the second stage deployed the satellite into

TradingKey - After the market close on April 16, streaming giant Netflix delivered a seemingly impressive Q1 earnings report: revenue grew 16% year-over-year to $12.25 billion, exceeding the market expectation of $12.17 billion; earnings per share (EPS) reached $1.23, nearly doubling from $0.66 in t

TradingKey - Allbirds surged 600% after announcing a full pivot to GPU leasing as NewBird AI. Shares pulled back 30% the next day. Key support $10, targets $13.30 and $15.90.

TradingKey - Following Nvidia’s launch of the Ising model, the quantum computing sector was rapidly galvanized; however, a company’s own commercialization progress remains the true determinant of its investment value. In comparison, IonQ’s revenue growth and execution capabilities are clearer, while QUBT is in an earlier stage, offering greater potential upside along with higher risk.

TradingKey - As the U.S. Dollar Index continues to pull back from its highs amid easing geopolitical tensions and weakened rate cut expectations, the Japanese yen, instead of strengthening, has persistently hovered around the key psychological level of 160, repeatedly nearing the Japanese authoritie